ArticleFrontiers in endocrinology2026
Effects of robotic walking on bone and muscle health in youth with neuromotor impairments: a five-participant case series.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction/Background: Bone and muscle health is a significant concern among individuals with neuromotor impairments, especially those with the greatest functional limitations. This case series presents the bone and muscle adaptations in response to 13 to 14 weeks of robotic walking in children and adolescents with neuromotor impairments. Methods: To ensure that the intervention targeted functionally meaningful outcomes, the Canadian Occupational Performance Measure (COPM) was used to capture family-centered goals and motivations for participating in robotic walking. Peripheral quantitative computed tomography (pQCT) scans of the tibia assessed bone and muscle health at three locations: the 3% (trabecular bone), 38% (cortical bone), and 66% (muscle) of tibia length. Scans were acquired before and following robotic walking in five participants with the greatest functional limitations [Gross Motor Function Classification System (GMFCS) levels III -V and Functional Assessment Questionnaire (FAQ): Functional Walking Scale levels 1 -5; aged 4 -12 years]. Bone and muscle outcomes were converted to age-, sex-, and ethnicity-matched Results: In some participants, clinically relevant improvements were observed in trabecular bone mineral density (BMD) (three participants), total bone mineral content (one participant), and cortical BMD (one participant) following robotic walking, suggesting promising bone adaptations. Conclusions: Results underscore the need for larger longitudinal studies to explore the impacts of robotic walking across various GMFCS and FAQ levels.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.